BRK.B 143.94 Berkshire Hath Hld B $BRK.B Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 10:33 AM

BRK.B 143.94 Berkshire Hath Hld B $BRK.B Hit a 52 week high of 144.79 Currently at 143.94 +0.33 +0.23% With a day low of 143.88 and a total volume of 499,792.

BRK.B Berkshire Hath Hld B Recent Headline News

Berkshire's earnings down 9 percent from year ago
By JOSH FUNK - AP - Fri Nov 07, 5:53PM CST
OMAHA, Neb. (AP) — Warren Buffett's Berkshire Hathaway reported a 9 percent drop in third-quarter profit versus the same period a year ago, when the company had large investment gains.
KO: 42.26 (-0.06), WFC: 53.88 (+0.04), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Warren Buffett's Berkshire Hathaway Beats 3Q Earnings Estimates
at The Street - Fri Nov 07, 5:27PM CST
Warren Buffett's Berkshire Hathaway posted third-quarter financial results after the bell on Friday, exceeding analyst estimates.
KO: 42.26 (-0.06), IBM: 163.67 (+1.60), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

BH Media Group Selects RX Savings Solutions To Achieve Pharmaceutical Savings
PR Newswire - Thu Nov 06, 12:35PM CST
BH Media Group, a Berkshire Hathaway company, has selected Rx Savings Solutions to provide a cost-effective answer to increasing prescription drug expenses. Rx Savings Solutions is the innovator behind a patented software system that helps organizations and their employees save money on pharmaceutical costs.
BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

5 Huge Stocks to Trade for Gains This Week: Berkshire Hathaway, Facebook and More
at The Street - Thu Nov 06, 11:14AM CST
Here's this week's look at five big stocks to trade this week.
TOT: 58.16 (+0.03), FB: 74.98 (-0.62), AMT: 98.88 (-0.59), EMC: 29.10 (-0.02), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Buffett Valuation Model Indicates Stock Market is Overvalued
Jaimini Desai - Amigobulls - Wed Nov 05, 11:00PM CST
Is market overvalued? Warren Buffet who is known for value investing developed 'Buffet indicator' to answer precisely this question.
BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Can Berkshire Hathaway (BRK. Earnings Surprise in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 3:20PM CST
Berkshire Hathaway Inc. (BRK. earnings are scheduled on Nov 7. It has an Earnings ESP is 0.00% and a Zacks Rank #2 (Buy), but our model does not conclusively show an earnings beat.
PFSI: 16.09 (+0.08), NAVG: 71.90 (+1.35), BRK.B: 144.24 (+0.63), KMPR: 36.95 (+0.04)

41 Billionaires: Meet the Richest Person in Every U.S. State
at The Street - Sat Nov 01, 9:11AM CDT
No matter where you live, there's someone living nearby who is richer than you are -- unless you're on this new list out from Wealth-X.
CLR: 55.86 (+0.73), CCL: 40.17 (-0.23), NKE: 94.22 (+0.44), GMCR: 154.36 (+1.46), WMT: 79.23 (+0.46), LVS: 59.60 (+0.07), ORCL: 40.06 (+0.12), DISH: 63.70 (-0.01), HUN: 24.75 (+0.06), HCA: 66.35 (+0.60), LB: 76.08 (+0.47), BRK.B: 144.24 (+0.63), MSFT: 48.59 (-0.09)

Average Grade for Q3 Earnings Season - Earnings Preview
Sheraz Mian - ZACKS - Fri Oct 31, 6:31AM CDT
Average Grade for Q3 Earnings Season - Earnings Preview
WFM: 47.13 (+0.32), HLF: 38.07 (+0.57), TSLA: 237.98 (-2.22), ADM: 50.52 (-0.03), S: 4.81 (+0.09), DIS: 89.43 (-0.57), WMT: 79.23 (+0.46), AIG: 54.09 (+0.06), KORS: 70.04 (+0.09), BRK.B: 144.24 (+0.63), PCLN: 1,097.54 (+2.93), HUM: 132.17 (+1.59)

Retirement Isn't a Pipe Dream -- and Here's How to Make It Happen
at The Street - Fri Oct 31, 5:10AM CDT
For many people, being able to retire seems impossible. But these 11 people can help you save enough to quit.
VOO: 186.48 (-0.02), MORN: 69.80 (+0.29), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Buffett's newspaper unit selling marketing firm
AP - Tue Oct 28, 3:26PM CDT
OMAHA, Neb. (AP) — Berkshire Hathaway's media unit is selling its marketing company to a Wisconsin group, so it can focus more on its newspapers.
MDLZ: 37.58 (-0.18), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Buffett's adviser picked to lead Pampered Chef
AP - Mon Oct 27, 2:06PM CDT
OMAHA, Neb. (AP) — One of Warren Buffett's key assistants is taking on a new role at Berkshire Hathaway as CEO of the conglomerate's Pampered Chef subsidiary.
BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Short-sellers Are Outsmarting Warren Buffett In 2014
at The Street - Mon Oct 27, 9:33AM CDT
Short-sellers Outsmart Warren Buffett in 2014 by Adam Kommel, President of ActivistShorts.com New York – October 27, 2014 When short-sellers take positions opposite from Warren Buffett, it appea...
CBI: 55.66 (+0.08), IBM: 163.67 (+1.60), XOM: 96.73 (+0.14), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

Surprising Stocks That Performed Best for Billionaires in 2014
at The Street - Mon Oct 27, 7:48AM CDT
See the stocks that have performed the best for 19 billionaires who made their money investing.
BDSI: 15.86 (+0.36), ATHL: 58.37 (+0.03), VIPS: 24.18 (+0.84), ARII: 68.93 (+2.65), SBAC: 113.05 (-1.57), BIOF: 7.28 (+0.01), BKW: 32.35 (-0.25), LUV: 38.61 (+0.37), HCA: 66.35 (+0.60), LPDX: 5.22 (-0.01), DTV: 87.44 (+0.04), RCPT: 109.87 (+0.63), WMB: 55.46 (+0.08), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72), SBGL: 6.90 (-0.26), AN: 57.91 (+0.32)

Jack Bogle on Warren Buffett, Bill Gross and How to Invest in a Volatile Market
at The Street - Fri Oct 24, 5:20AM CDT
Jack Bogle dealt out investing ideas and warnings in an investor talk. Here's what he had to say.
VOO: 186.48 (-0.02), BRK.B: 144.24 (+0.63), GOOG: 543.23 (+2.22), BRK.A: 216,293.72 (+1,323.72)

12 Attractive Stocks for a Dramatically Improved U.S. Economy
at The Street - Wed Oct 22, 11:03AM CDT
The biggest change in the U.S. investment markets in the next year could be the coming rampage to buy houses by first-time homebuyers.
HD: 97.50 (-0.15), JPM: 61.78 (+0.31), EBAY: 53.51 (unch), CAB: 50.70 (+1.24), JWN: 72.52 (-0.91), DIS: 89.43 (-0.57), WFC: 53.88 (+0.04), CMCSK: 53.21 (-1.78), BAC: 17.37 (+0.01), BRK.B: 144.24 (+0.63), NVR: 1,241.02 (+6.52), HRB: 32.75 (+0.06)

Doug Kass: Why Does Warren Buffett Still Own Coke and IBM?
at The Street - Wed Oct 22, 6:11AM CDT
There's only one I can think of for Coke, and I am unsure on IBM.
KO: 42.26 (-0.06), IBM: 163.67 (+1.60), BRK.B: 144.24 (+0.63), BRK.A: 216,293.72 (+1,323.72)

'Mad Money' Lightning Round: I See Home Depot Going to $100
at The Street - Wed Oct 22, 5:00AM CDT
Cramer says buy Apple for the long term, Vectren is a hot utility and don't worry about Warren Buffett or Berkshire Hathaway.
73.81 (-0.08), HD: 97.50 (-0.15), VVC: 45.21 (-0.03), TXN: 51.38 (+0.48), BBRY: 11.15 (+0.62), CB: 101.78 (+0.64), BRK.B: 144.24 (+0.63), AAPL: 109.08 (+0.07), TRV: 102.99 (+0.62)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....